A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt

ConclusionsThe created MCDA tool is capable of objectively comparing similar off-patent oncology medicines by considering multiple value attributes and providing reliable scoring functions for each.
Source: Journal of Pharmaceutical Policy and Practice - Category: Pharmaceuticals Source Type: research